Sir Norman Lamb MP, Parliament of the United Kingdom
Sir Norman Lamb has been the Liberal Democrat MP for North Norfolk since 2001. After serving as a minister in the Department for Business, Innovation and Skills, he was appointed Minister of State for Care and Support at the Department of Health in September 2012 and served in this position until the end of the Coalition Government in May 2015. As Health Minister, he worked to reform the care system and led the drive to integrate health and social care, with a greater focus on preventing ill health. He also challenged the NHS to ensure that mental health was treated with the same priority as physical health, including the introduction of access and waiting standards in mental health for the first time. He was the Liberal Democrat Health spokesperson between 2015 and 2017, and was elected Chair of the Science & Technology Select Committee in July 2017.
Tahira Rehmatullah, MTech Acquisition Corp.
Tahira serves as Executive Director of Hypur Ventures, Partner at Ceylon Solutions, and CFO of MTech Acquisition Corp. From brand building to hedge funds, Tahira has previously held positions at Marley Natural, Privateer Holdings, City First Enterprises, Perry Capital, and Ernst & Young. She is an investor and advisor to numerous cannabis businesses and entrepreneurs and is dedicated to developing female and minority leadership in the industry. Tahira earned her MBA from the Yale School of Management and B.S. in Finance from The Ohio State University.
Andrew Neil, Press Holdings Media Group
Andrew Neil is a publisher, broadcaster and company chairman working out of London, New York, Dubai and the South of France. He is the current chairman of Press Holdings Media Group, whose titles include The Spectator, and the ITP Media Group. In addition to his business responsibilities, Andrew currently presents Politics Live and This Week on the BBC. He was a House of Commons political correspondent in London, White House correspondent in Washington DC and Wall Street correspondent in New York – all for The Economist. He was made British Editor of The Economist in 1982, and subsequently became Editor of The Sunday Times of London. During that time he served as Executive Chairman of Sky Television, which he launched in 1989 as Britain’s first multi-channel satellite TV platform. He created Sky News, now a £15bn company, and brought The Simpsons to British screens.
Steph Sherer, ICCI
Steph Sherer is ICCI's Director of Innovations, founder and Executive Director of Americans for Safe Access, and founding member of International Medical Cannabis Patients Coalition (IMCPC). Steph has become the foremost international leader and expert on medical cannabis patient advocacy and, alongside the American Herbal Products Association (AHPA), has created the first industry standards in the areas of distribution, cultivation, analytics, manufacturing, packaging, and labeling.
Navdeep Dhaliwal, The Supreme Cannabis Company, Inc.
Navdeep Dhaliwal is Chief Executive Officer and a Director of The Supreme Cannabis Company, Inc. He is an entrepreneur, financier and investor focused on ventures and initiatives that create positive global change. Mr. Dhaliwal has extensive knowledge and experience across industries including cannabis, renewable energy and technology. He believes that cannabis legalisation is a global game-changer that will have a positive impact socially, medically and as a recreational product. Mr. Dhaliwal is also a Director of Medigrow Lesotho, a Licenced Producer in the Kingdom of Lesotho.
Emily Paxhia, Poseidon
Emily has reviewed thousands of companies in the cannabis industry and has worked with countless founders in many capacities. She had helped to shape founders' pitch preparations, their go-to-market strategies/ product launches, and advised on day-to-day business operations. Emily has held board seats for three portfolio companies and participates as an adviser to multiple teams.
Extremely active in the investment decision making and ongoing investment oversight processes, she works closely with her partners to create meaningful deal structures, ensuring that proper governance is carried out at the company level. Further, Emily has dedicated time and energy to supporting policy groups and has served on the Board of Directors of the Marijuana Policy Project. She also currently serves on the Board of Athletes for CARE.
Eileen Burbidge, Passion Capital
Eileen Burbidge is a Partner at Passion Capital, the preeminent early-stage technology venture fund based in London and for whom she serves as non-executive director on a number of boards including Monzo Bank, Digital Shadows, Tide and Prowler.io among others. In addition to Passion Capital, Eileen is also the Chair of Tech Nation; HM Treasury’s Special Envoy for FinTech; Tech Ambassador for the Mayor of London’s office and served on former UK Prime Minister David Cameron’s Business Advisory Group. Eileen is also the board of Dixons Carphone, the FTSE 250-listed consumer electronics retailer.
George Kruis, fourfivecbd & England's international rugby team
George Kruis has been playing professional rugby for 10 years and is a seasoned international and British Lion. He has over 150 appearances for Saracens winning 2 European titles and 3 Premiership trophies. Now he wants to spread the word about the benefits of CBD. He founded fourfive along with Dom Day, and are committed to offering the highest grade CBD products available, designed to help maintain an active lifestyle.
Ricardo Baptista Leite MP, Parliament of the Republic of Portugal
Dr. Ricardo Baptista Leite is a medical doctor and Member of Parliament in Portugal, where he sits on the Health Committee and on the Foreign Affairs Committee. As a public health advocate, Dr. Baptista Leite championed a motion to endorse cannabis legalisation. He is Head of Public Health at the Institute of Health Sciences of the Catolica University of Portugal and Coordinator of the Sustainable Healthcare Unit at the NOVA Information Management School.
Bardhyl Dauti, Government of the Republic of North Macedonia
Bardhyl Dauti, Ph.D. – is a minister without portfolio in the Government of the Republic of North Macedonia, in charge of attracting foreign investments. Mr Dauti obtained a master degree from the Staffordshire University, UK, and a PhD in economics at the University of Ljubljana, Republic of Slovenia, with a successful defense of the PhD thesis: Determinants and Trade Effects of Foreign Direct Investments in South East European Countries, with a special focus to Macedonia. Minister Bardhyl Dauti also serves as a visiting professor at the Faculty of Economics, at the University of Ljubljana, covering mainly economics related subjects of Macroeconomics and International Economics.
Andrea Paine, Aurora
Andrea Paine is National Director of Government Relations at Aurora Cannabis. She is the lead director for federal and provincial government relations, community relations with municipalities and local non-profit associations, and is leading collaborative GR efforts in Europe. Before joining Aurora, Andrea had a long professional career in politics and government. She worked for over twenty-five years with cabinet Ministers in Quebec provincial departments of Food and Fisheries, Transport and Education, and Federal Ministers of Human Resources and Social Development, Heritage, Health, as well as with the Government House Leader.
Vivien Azer, Cowen Inc.
Vivien Azer is a Cowen managing director and senior research analyst specialising in the beverage, tobacco, and cannabis sectors. She is the first senior Wall Street analyst to cover the emerging cannabis sector, resulting in notable global press coverage across key media outlets. Her coverage of the tobacco and cannabis sectors has earned her industry accolades including a spot on Institutional Investor’s All-America Research Team and she has consistently been ranked by Thomson Reuters Analyst Awards.
Delano Seiveright is Senior Advisor and Tourism Communications Strategist to Jamaica’s Government and a leading Cannabis law reform advocate, who in part piloted Jamaica's liberalisation in 2015. He is one of the youngest members of the ruling Jamaica Labour Party's Central Executive. He is a Director for several Government of Jamaica boards including Jamaica Promotions (JAMPRO), which promotes business opportunities in export and investment and the Cannabis Licensing Authority (CLA), which regulates Jamaica’s legal cannabis industry.
Dr. Marco Van de Velde, Dutch Office for Medicinal Cannabis
Dr Marco van de Velde is the head of Office of Medicinal Cannabis (OMC) in the Netherlands. After completing a PhD on the modulatory role of fatty-acid metabolites in the signal transduction cascade in inflammatory processes, he continued his career as senior policy advisor at the Ministry of Health in the Netherlands and was responsible for implementation of new legislation on pricing and reimbursement of pharmaceutical products and quality standards for human tissues.
Dr. Barbara Pacchetti, EMMAC Life Sciences
Barbara is the Chief Scientific Officer of EMMAC Life Sciences. She is a seasoned executive with over 20 years of experience in the pharmaceutical and nutraceutical space in Europe and globally. Her length of industry experience has enabled her to develop expertise and leadership in areas such as Life Science research, Innovation and R&D, Process technology, intellectual property and project management researching natural compounds and bioactives.
Dylan Kennett, DLA Piper
Dylan is a Senior Associate in DLA Piper's corporate team. His practice focuses on venture capital, private equity and M&A (both domestic and cross-border) - as well as advising on intellectual property matters. He acts for high-growth businesses, investors and other stakeholders. He focuses on the tech, media, sport and cannabis sectors. He is co-lead of the firm's Emerging Growth and Venture Capital practice.
Kim Wilson, GCP
Kim Wilson is the Executive Director of the Global Cannabis Partnership, a collaboration of leaders in the cannabis industry creating international standards for safe and responsible production, distribution and consumption. Prior to joining GCP, Kim spent 11 years at Atlantic Lottery Corporation (ALC) as Manager of Corporate Social Responsibility.
Mark Reinders, HempFlax
Mark Reinders has been at HempFlax since 2008 prior to being appointed as CEO of the HempFlax group in 2016. Raised in a farming family, Mark holds bachelor’s degrees in agri-business and crop production from Het Van Hall Instituut, and earned a Master of Science degree in management from Nyenrode University. He has served on the board of directors of the European Industrial Hemp Association since 2008, prior to being elected President of the Association in June 2016.
Steve Barron, Margent Farm
Steve Barron s a British film director, film producer, writer, and music video director, responsible for Michael Jackson’s Billie-Jean and A-Ha’s ‘Take On Me’. He also directed Teenage Mutant Ninja Turtles (1990), the first independent to take $100 million in the US, and ‘Coneheads’ starring Dan Aykroyd. More recently Steve has pioneered researching and developing Bio-Plastics from industrial hemp at his Margent Farm in Cambridgeshire.
Tjalling Erkelens, Bedrocan
Tjalling Erkelens is the co-founder and CEO of Bedrocan, the sole supplier of medical cannabis to the Dutch Office for Medicinal Cannabis. Educated as a teacher and journalist, Tjalling started a horticultural company with brother-in-law Freerk Bruining. In 1992 the group grew their first cannabis crop for seed production. Today Bedrocan is a leading and world renowned European cannabis company.
Dr Ellie Cannon, NHS
Dr Ellie Cannon, is an NHS GP, broadcaster and author. She is a regular on Sky news, LBC and Talk Radio discussing a range of health topics including the prescription of cannabis on the NHS and its logistics. She also writes a weekly column for the Mail on Sunday.
Dr David Casarett, Duke Center for Palliative Care
David Casarett MD MA is a palliative care physician, researcher, and Director of the Duke Center for Palliative Care. He is the author of more than 150 scientific articles and his writing has appeared in Salon, Esquire, Discover, Newsweek, the New York Times, and Wired. He has also written two novels and three non-fiction books, the most recent of which was Stoned: A Doctor’s Case for Medical Marijuana.
Hannah Deacon, Carer & Campaigner
Hannah Deacon is the mother of Alfie Dingley, a six-year-old boy with a rare form of epilepsy. When Hannah and Alfie moved to Holland for five months to access medicine containing THC, Alfie's condition improved dramatically, after which Hannah became the first person to legally enter UK with cannabis oil to help her son in June 2018. She now leads the campaign group End Our Pain, working with 18 families who have not been allowed to apply for a licence as they do not have their doctor’s backing. She also works as Patient Advocacy Specialist for ECH.
Cam Battley, Aurora
Cam Battley is Chief Corporate Officer of Aurora Cannabis, one of the world’s largest and fastest growing cannabis companies. As a senior healthcare industry leader and strategist with more than 20 years of international experience, Cam is the lead external-facing executive of Aurora, responsible for establishing and managing relationships with shareholders, analysts, media, regulators, governments, and other companies and organisations operating in the cannabis sector. He also chairs the Executive Committee, acts as liaison with the Board, and ensures organisational alignment across the Company's operations, domestic and international.
Gustavo Escobar, Clever Leaves
Gustavo Escobar is the Co-Founder and Chief Innovation Officer at Clever Leaves. He has extensive leadership experience with proven results in the corporate environment and the entrepreneurial ecosystem in Colombia. He has extensive experience in executive management and the exponential development of new businesses, as well as commercial management and the implementation of technology research and development projects mainly in the healthcare, financial and telecommunications sectors.
Catherine Jacobson, Tilray
Catherine identifies opportunities for clinical research partnerships that fulfill Tilray's goal of advancing knowledge of cannabinoid science by partnering with physicians and medical institutions to generate data that will inform best treatment practices. Prior to joining Tilray, Catherine led a venture philanthropic fund addressing the lack of adequate drugs and devices to treat pediatric epilepsy. Before that, she served as a post-doctoral fellow at the University of California, San Francisco where she established GW Pharmaceuticals' Expanded Access Investigational New Drug Application (IND) for Epidiolex for the treatment of children with severe medically refractory epilepsy.
George McBride, Hanway Associates
George McBride is a former commercial barrister turned cannabis reform advocate and industry consultant based in London, UK. George was part of the founding team who setup Volteface, the UK’s leading think tank driving the debate around cannabis reform. He’s also a co-founder of Hanway Associates, London’s global cannabis consultancy; a team of creatives, consultants and academics. They consult, connect and communicate to bridge the gaps between industry, academia and policymakers. He started his professional career in cannabis policy at the Beckley Foundation, a pioneering think tank driving research into the medical applications of cannabis and the psychedelics.
Derek Riedle, Civilized
Derek Riedle is Founder and Publisher of Civilized, leading lifestyle brand and multiplatform media company that speaks to the millions of adults who chose to enjoy cannabis as a healthy part of a balanced lifestyle. An award-winning entrepreneur, political advisor, television producer and creative story-teller, Derek is igniting positive change in the global cannabis industry and helping shatter outdated stigma.
Stephen Murphy, ECH
Stephen is Co-Founder and Group Managing Director of ECH, an unrivalled group of companies at the forefront of the medical cannabis industry. As a cannabis specialist focused on developing the legal European cannabis industry, Stephen is also the co-founder of Prohibition Partners and of Cannabis Europa. With a background in technology, digital media and corporate finance, Stephen works with investors, entrepreneurs and regulators to identify, qualify and maximise the opportunities in this emerging frontier.
Rebecca Brown, Crowns
Rebecca Brown is the founder of Crowns, a one-stop shop for experts in every aspect of building a new cannabis retail experience: design, regulation, marketing, government relations, branding, and customer experience. Crowns is writing the playbook for cannabis marketing and designing solutions to grow cannabis brands within the constraints of regulation.
Hannah Skingle, Dragonfly
After topping the Tripos at King’s College London and completing a MSc in Management at the London School of Economics, Hannah spent her early years as an analyst at biotech company The RSA Group and prop-tech start-up Goodlord. Quickly moving to make her mark on Dragonfly, she progressed from Business Development Associate to COO within a year. She has played a key role in building the company’s backend, with a clear focus on European Cannabis licensing and regulation. She is now the company’s resident expert.
Nick Pateras, Lift & Co.
Nick Pateras is Vice President of Strategy at Lift & Co., Canada’s leading cannabis media and technology platform. Prior to joining Lift & Co., Nick spent several years in the pharmaceutical sector with Johnson & Johnson. His background in healthcare led him to make the professional move into cannabis, having long advocated for recognition of its many medical applications.
Nick Davis, Memery Crystal
Nick Davis is the Chief Executive of Memery Crystal and a Senior Partner in the firm’s Corporate team. Memery Crystal are the leading UK law firm on advising the emerging cannabis sector on business set-up, capital markets, mergers and acquisitions, private fundraising, licencing and commercial contracts. Nick is currently advising a number of cannabis companies and recently led the Memery Crystal team on the NEX listing of medicinal cannabis investment vehicle Ananda Developments - the second ever public listing of a cannabis vehicle. Nick has a personal interest in medicinal cannabis as a Trustee of the charity ‘Olivia's Vision’, the UK's leading uveitis charity raising awareness of the condition from which his daughter, Olivia, suffers.
Georgina Carr, MS Society
Georgina is Head of Campaigns and External Relations at the UK MS Society and member of the European Multiple Sclerosis Platform (EMSP) Executive Committee. She works to ensure that policy reflects the needs of people with MS, on issues like access to treatment, welfare, and social care. Prior to her role at the MS Society, Georgina worked in Brussels on EU health policy for the consultancy Burson Marsteller.
Sue Mountstevens PCC, Avon and Somerset
Sue Mountstevens is a British independent politician. Since November 2012, she has been the Avon and Somerset Police and Crime Commissioner. She is the first person to hold the post and was elected on 15 November 2012, having stood as an independent candidate. She has been vocal in urging a new community approach on cannabis, focused on changing perceptions and giving opportunities to people to exit the cycle of crime.
Michael Prytz, Ministry of Foreign Affairs of Denmark
Aa an Investment Manager at Invest in Denmark, Michael Prytz helps Canadian and US based companies establish their businesses in the Danish market. The goal is to sustain and grow Danish jobs and wealth creation while making it possible for companies to realise business opportunities and optimise the potential Denmark has to offer to the fullest.
Pamela Hadfield, HelloMD
Pamela Hadfield is a tech entrepreneur and co-founder of HelloMD, the largest online community of health and wellness cannabis consumers. After treating her debilitating migraines with cannabis successfully, Pamela launched HelloMD, initially as a telehealth service designed to connect medical cannabis patients with doctors. Over the past 4 years HelloMD has seen over 100k patients on their platform. They have since expanded to include educational content and cannabis sales within California and CBD sales across the United States.
Valentina Milanova, Daye
Valentina Milanova is the founder and CEO of Daye, a femcare R&D company. Through Daye, Milanova is on a mission to raise the standards of women's hygiene products, and to introduce the world’s first cramp-fighting CBD tampon.
Alfredo Pascual, Marijuana Business Daily
Based in Germany, Alfredo Pascual works as International Analyst for Marijuana Business Daily, focusing on international cannabis markets and regulations. He has an academic background in business and public policy. Before joining MJBizDaily, he founded Transnational Cannabis, a regulatory consultancy firm that had clients in Europe and Latin America. Previously, he did business development for ICC Labs with a primary focus on developing expansion opportunities internationally.
Barinder Bhullar, The Supreme Cannabis Company, Inc.
Barinder Bhullar is the Vice President, Government Relations and International Affairs, at The Supreme Cannabis Company, Inc. Mr. Bhullar leads domestic and international government relations and guides Supreme Cannabis' global market strategy for medical cannabis. Mr. Bhullar brings more than a decade of experience as a trusted public affairs strategic advisor. He has served in a variety of senior roles within government, including as the Director of Policy in the office of the Premier of British Columbia, as well as Chief of Staff to the B.C. Minister of Health.
John Binns, BCL Solicitors LLP
John Binns is a partner in the business crime and corporate regulatory department of BCL Solicitors LLP in London. He specialises in proceeds of crime issues (including in the context of overseas cannabis investments), and also regularly advises clients on Home Office licensing issues under the Misuse of Drugs Regulations.
Michael Sprenger, HAPA Medical
After graduating from the Frankfurt School of Finance & Management, Michael Sprenger started his career managing hedge funds up to €1.5 billion in assets for institutional investors in derivative strategies. Building smaller companies on the side he moved into the start-up industry in Berlin. He worked for the most successful venture builders in Germany (Rocket Internet, Ioniq) hands-on in early stage start-ups bringing them to speed operationally.
Sabah Meddings, The Sunday Times
Sabah Meddings is a business report for The Sunday Times where she covers medical cannabis topics and development of industry.
Everett Knight, Valens
Mr. Knight is Executive Vice President of Strategy & Investments at Valens where he oversees corporate strategy including mergers & acquisitions, marketing, & investor relations. Mr. Knight is known across the cannabis space for his expertise and thought leadership where he has been involved with working, analysing, lobbying, investing, advising, & consulting throughout the cannabis value chain. He has toured over 85 facilities worldwide and analysed over 1200+ cannabis globally where he accumulated a thorough understanding of the industry, regulations, subsectors, and the companies involved in this fast-growing space. His focus in the cannabis industry has shifted in recent years to developing a specialty in extraction, testing, formulation, & value-added products.
Deepak Anand, Materia Ventures
Deepak Anand is recognised as a thought leader in the global cannabis space. He currently serves as the co-founder and CEO of Materia Ventures, a European-focused supply and distribution company for medical cannabis and CBD products. He previously served as VP of business development and government relations at Cannabis Compliance Inc. as well as VP of Canadian licensed producer Zenabis. He is a board member for several for and not for profit cannabis businesses and industry associations across North America and Europe.
Boris Baňas, CBDepot.eu
Boris Baňas has been a hemp activist since 1998 and working in industrial sector on various mid and top management positions between 2000-2009. Bañas is a Member of Board of the European Industrial Hemp Association (EIHA). He grew hemp for research under Slovak government licences in 1999, 2000 and 2003. He also helped to push Slovakia's government to adopt EU hemp-related farming rules in 2008. He launched CBDepot.eu in 2014 with the aim of providing legal and quality Cannabidiol-enriched products for industrial and end-consumer use.
Aras Azadian, Avicanna
Utilising his extensive senior management experience in both financial and biotechnology sectors, Aras co-founded Avicanna with the vision of establishing a biopharmaceutical company with a strict focus on medical and pharmaceutical applications of cannabinoids. His expertise in corporate development coupled with his executive experience in the oncology industry have been integral to Avicanna’s thought leadership pertaining to R&D and clinical development. Since 2016 Aras has successfully led a team of executives, scientists and medical professionals across several countries with the vision of vertical integration and a strong company focus on quality controls, scientific vigor and competitive advantages. Aras holds a Bachelor of Economics degree from York University and an International Masters in Management degree from EADA Business School in Barcelona, Spain.
Drake Sutton-Shearer, PRØHBTD
Drake Sutton-Shearer is the CEO and Founder of PRØHBTD, a hybrid consumer goods and content company. With a mission to lead cannabis from the black market to the supermarket, PRØHBTD is recognized as the worldwide cannabis partner of Licensing Expo, Entrepreneur Magazine, Advertising Week and Postmedia. The company is venture backed with $20M+ in funding with offices across North America. Drake is a cannabis industry thought leader and serial entrepreneur who has created more than $600M in value from his enterprises across lifestyle brand building, music, social tech and IP.
Jonathan Zaid, Aurora
Jonathan Zaid is the Director of Advocacy and Corporate Social Responsibility at Aurora Cannabis Inc., one of the world’s largest legal cannabis companies. His responsibilities include overseeing the development and implementation of Aurora’s global CSR and advocacy initiatives. Jonathan also sits on the C3 industry association’s Medical Cannabis Committee. He founded Canada’s foremost non-profit cannabis patient advocacy organisation, Canadians for Fair Access to Medical Marijuana (CFAMM).
Melanie Goldsmith, Smith & Sinclair
Melanie Goldsmith, the founder of Smith & Sinclair, has built an empire based on edible alcohol. From alcoholic pastilles to spiked sherbet, Smith & Sinclair play on the idea of 'eating your drink'. Smith & Sinclair creates innovative products & experiences that range from patented alcoholic cocktail gummies through to effervescent tablets you can drop in prosecco to turn it into a mindblowing cocktail.
Prof. Tamara Lah Turnšek, University of Ljubljana
Prof. Tamara Lah Turnšek holds a PhD from the University of Ljubljana, Slovenia and is the former Director of the National Institute of Biology and established Department of Genetic Toxicology and Cancer Biology. At present she is a Scientfic Councillor and professor of Cancer Biology at the University of Ljubljana. She has previously worked at Josef Stefan Institute in Slovenia and the University of Newcastle upon Tyne, UK. She also a was postdoc and Assist. Professor at the School of Medicine in WSU in Detroit, Director of Metastasis Research Laboratory at Albert Einstein Medical Centre, in Philadelphia, PA and recently a Visiting Professor in Sao Paolo University in Brasil.
Kris Krane, 4Front
Kris Krane founded 4Front in 2011 and now serves as president of 4Front. Prior to forming 4Front, Kris served as director of client services for CannBe, a pioneer in developing best practices within the medical cannabis industry. Kris has dedicated his career to reforming the nation’s misguided drug policies, having served as associate director of NORML from 2000 to 2005 and executive director of Students for Sensible Drug Policy from 2006 to 2009. He currently serves on the National Cannabis Industry Association board of directors.
Crispin Blunt MP, British Parliament
Crispin Blunt was elected to Parliament as the MP for Reigate in 1997. He has held a number of Opposition frontbench roles, with briefs covering Northern Ireland, trade and energy, and security and counter-terrorism. From May 2010 until September 2012 he was Minister for Prisons, Probation and Youth Justice and from June 2015 to May 2017, he served as Chairman of the House of Commons Foreign Affairs Select Committee. Crispin is currently co-chair of the All Party Parliamentary Group (APPG) on Drug Policy Reform, co-chair of the All Party Parliamentary Humanist Group, co-chair of the new APPG for London's Green Belt as well as the secretary of the APPG on Global LGBT Rights.
Douglas Gordon, Zimmer Global
Douglas has almost 30 years work experience spanning finance, media, sales and marketing. He serves as Chairman of Zimmer & Co. a medicinal cannabis and hemp-based CBD health and wellness distribution business, since its inception in 2017, where he inspires and leads the team to new markets and opportunities. In 2016, he founded CanEx Jamaica - the premier Cannabis Business Conference & Expo that takes place in the Caribbean.
Elisabetta Faenza, LeafCann Group
Elisabetta's journey was prompted by a childhood diagnosis of a rare, deadly genetic condition, which led her on a quest to understand how our bodies, medicines, nutrition and the environment interact to switch damaging genes on and off. Before co-founding LeafCann Group, an Australian licenced Medicinal Cannabis company now also operating in the UK, Elisabetta’s work as a clinical hypnotherapist, corporate speaker and mentor assisted thousands of individuals to change unwanted behaviours, recover from trauma and achieve personal and career goals. Prior to LeafCann Elisabetta was founding CEO of the Mulloon Institute, a regenerative farming research institute, and was a senior executive in the Nutraceutical sector. In LeafCann, Elisabetta has brought together a talented team of experts from biomedicine, clinical research, quality assurance, education and training, controlled medicinal cannabis cultivation, extraction, policy, project management, facility design, regulatory affairs and IP management. Elisabetta manages a global team on three continents, all working to produce the highest quality Medicinal Cannabis products under GMP.
William Muecke, Artemis Growth Partners
William Muecke is a co-founding managing member of Artemis Growth Partners LLC, an impact-oriented private equity platform dedicated 100% to investing in the cannabis industry on a worldwide basis. William is former global co-head of healthcare services investment banking at Goldman, Sachs & Co. (New York), and co-founding managing general partner of CoreCo Private Equity (San Jose), 2017 GIIRS "Best for the World" impact fund backed by investors including the IFC/World Bank, and the multilateral/development banks of Germany, Norway, Switzerland, Belgium, the IADB, and UHNW individuals and European family offices.
Samantha Myers, Gowling WLG
Samantha Myers is a Director in Gowling WLG's Corporate group and leads the firm's UK Cannabis group. She specialises in corporate finance, mergers and acquisitions and equity capital markets, and is currently advising on a number of cannabis related mandates. She has extensive experience of acting for companies, or their advisers, on IPOs and secondary transactions, and regularly advises on a range of domestic and cross border M&A transactions, including public takeovers. Gowling WLG is an international law firm with more than 1,400 legal professionals in 19 cities worldwide. The firm has a leading Cannabis practice in Canada and a fast-growing practice across Europe and the UK.
Roderick Stephan, Altitude Investment Management
Roderick Stephan is a founding partner of Altitude Investment Management LLC, a cannabis investment management company managing investments in North America and Europe. As a mentor and advisor to early-stage and growth cannabis companies, he sits on a number of corporate boards. He was previously a founding partner of Longacre Fund Management (UK) LLP, a London-based alternative investment adviser managing and co-founder of the of the Distressed Investments Group at Citadel Investment Group.
Michael Bennett, Hill Dickinson
Michael Bennett is the head of Hill Dickinson’s corporate and commercial team in London which advises clients on a broad range of transactions with a focus on UK and international flotations, reverse takeovers, placings, open offers and dual listings (including Canada, South Africa and Australia). More recently, Michael and the Hill Dickinson team have worked on the interpretation and application of the laws in the UK in relation to medicinal cannabis and advised on the first medical cannabis investments by a UK listed company on AIM and on the first medical cannabis IPO in the UK since 2001.
Patrick Harte, Farm Frontiers
During Patrick’s Harte’s 10+ year career in ABF he led the former tomato growing business Cornerways Nursery; an 18ha tomato glasshouse. He then transformed the business, now named Riverside Nursery into Cannabis production. He is currently CEO of Farm Frontiers, and is currently raising funds to develop Vertical Farming technology to be able to remotely grow crops anywhere in the world.
Alexandra Curley, Prohibition Partners
Alexandra is Head of Insights at Prohibition Partners, providing market data and intelligence to key stakeholders in the industry. She is responsible for industry-first reports across a range of newly emerging cannabis markets and is regularly quoted in the international media as a key forecaster for the global cannabis industry. With experience gained the large market research houses and as an independent consultant, Alexandra’s career in insight-driven data analysis spans almost 20 years.
Robert Cookson, Hanway Associates
Robert Cookson is a consultant at Hanway Associates. He advises companies on how to enter and build their businesses in Europe's legal cannabis markets. His work includes regulatory forecasting, competitive analysis and market sizing. Previously, Robert spent nearly a decade as a journalist at the Financial Times in London and Hong Kong, covering a range of topics from technology and media to Asian financial markets. He has also worked at Amazon and Piton Capital, a venture capital fund. He has a degree in Experimental Psychology from the University of Oxford and an MBA from London Business School.
Leigh Hughes, Next Green Wave
Leigh is an integrated marketing communications and innovations professional of 15+ years. He has held board level positions for multiple companies and has success and experience in venture capital services and the commercialisation of private and public companies across the globe, in particular: North America, Australia, and the Asia Pacific Region. He is currently a corporate advisor to multiple listed companies on the CSE and TSXv.
Diana Gutiérrez, Linneo Health
Diana Gutiérrez studied Pharmacy at Alcalá University in Madrid and has more than 15 years experience in pharmaceutical industry in various positions in the Quality field (e.g. Process and Cleaning validation, Quality Assurance Manager, Qualified Person, and Head of Quality), being specialised in pharmaceutical sterile production. Since June 2018, she is responsible for the establishment and management of the Quality System, ensuring the quality, safety and efficacy of the narcotic intermediates and APIs manufactured by Alcaliber.
Henry Fisher, Hanway Associates
Dr Henry Fisher is a co-founder and Chief Scientific Officer of Hanway Associates, London’s global cannabis consultancy, as well as co-founder of Cannabis Europa, Europe's foremost medical cannabis conference. He is the R&D Project Manager for Grow Biotech, where he leads on the company's UK-based R&D operations. Henry completed a DPhil in pharmaceutical chemistry at the University of Oxford, where his studies focused on formulation of psychoactive pharmaceuticals. He started his professional career in cannabis policy at the Beckley Foundation, which researches the medical applications of cannabis and psychedelics. He was part of the founding team of Volteface, the UK’s leading drug policy think tank, where his work focussed on medical cannabis and night time economy policy.
Anne Schlag, King's College London
Dr Anne Katrin Schlag is Head of Research at DrugScience and Honorary Fellow at Imperial College London. Anne Katrin has a keen interest in the social, ethical and moral dimensions of national and international drug policies, related regulatory challenges and public communications. Her current research focuses on controversies surrounding medical cannabis and on the application of the MCDA approach to drug regulation, together with Prof David Nutt and Prof Larry Phillips.
Lewis Cameron, Medcann
Head of Research & Development, Medcann Pharma With more than 25 years in preclinical and clinical drug development, Lewis Cameron serves as the Head of Research & Development at Medcann Pharma. Lewis has worked with small and large companies in the biotechnology sector, central laboratories and CROs and has experience in all phases of drug development across many Therapeutic Areas including Oncology, CNS and Pain. As an accomplished senior executive, Lewis has a proven track record in delivering outstanding operational and commercial results in challenging and innovative market sectors. Prior to Medcann he was Global Head of Clinical Development at Covance, and prios to that as Chief Executive Officer at the biotech, Avillion. Lewis earned his bachelor’s degree from Edinburgh University, a master’s degree in biotechnology from the University of Reading and his MBA from Instituto de Empresa in Madrid. He is based in Madrid, Spain.
Tom Powell, Jacana
Tom Powell is the current SVP of Corporate Affairs for Jacana, a former venture capitalist with 5 years experience in financial services and a former HM Treasury InsurTech board member. He previously spent 10 years in professional sports as England Rugby Sevens captain with 43 caps, including a Rugby 7s World Cup runners up medal.
Camilla Horsfall, Blytheweigh
Camilla Horsfall is a Director at Blytheweigh, a boutique London financial PR Firm and one of the leading for cannabis stocks. Blytheweigh represents companies on all global exchanges, establishing their reputations and then promoting them to journalists, sell-side analysts and investors. With the changes in regulation, a number of companies are coming to IPO in London. Blytheweigh is advising cannabis clients on marketing, regulation, branding, as well as messaging and crisis communications which are essential in a new, and sometimes contentious, industry such as this.
José Ricardo Puyana, Embassy of Colombia to the United Kingdom
José Ricardo Puyana is Minister Counsellor for Political and Economic Affairs at the Colombian Embassy to the UK where he leads on the implementation of the bilateral cooperation agenda on strategic fronts such as trade and investment, science and innovation, and green growth. Before joining the Embassy, he held several managerial positions in the Colombian government as well as in the United Nations.
Roland Harwood, Liminal
Roland Harwood is founder of Liminal, a new network for people, organisations and communities on the edge of many potential futures. Prior to that he was Co-Founder and Managing Director at 100%Open, the multi award-winning open innovation agency that works with the likes of LEGO, Ford, UBS, Oxfam and in 25+ countries around the world to co-innovate with their partners.
Nicholas Vita, Columbia Care LLC
Nicholas Vita has over 25 years of experience serving in corporate leadership roles, investing capital, structuring and funding public/private partnerships and providing strategic advisory services to Fortune 500 companies throughout the U.S., Europe, Asia and Latin America. Prior to Columbia Care, Nicholas was a Partner and served as the Chairman of the Investment Committee at Apelles Investment Management, LLC, a private investment management company focused on the healthcare and privatized military infrastructure sectors. Before Apelles, Nicholas was a General Partner, member of the Investment Committee, and the Portfolio Manager for the Healthcare Sector at ARX Investment Management, a multi-billion dollar global credit hedge fund. Previously, he worked in the Investment Banking Division at Goldman, Sachs & Co. Inc., as an Analyst, Associate and Vice President in the Healthcare Department focused on Mergers, Raid Defense and Corporate Finance.
Dean Billington, Brains Bioceuticals
Dean is the Chief Science Officer at Brains Bioceuticals. Dean is a consultant with a proven track record in providing comprehensive support services to all areas of the Pharmaceutical, Biotech and Healthcare industries which need to meet the exacting standards and expectations of the global pharmaceutical industry. Prior to Brains, Dean was a QP Consultant at BSPG Laboratories.
Blair Gibbs, Centre for Medicinal Cannabis (CMC)
Blair Gibbs is public policy consultant and government relations advisor based in Canada. He specialises in policy, regulations and political developments affecting legal cannabis markets. Prior to relocating to Canada, Blair served for 4 years in the UK government, as a senior advisor to the Secretary of State for Justice and prior to this as a mayoral advisor for Boris Johnson at City Hall in London. In both roles he formulated policy around policing, criminal justice diversion, drug treatment services, therapeutic courts, and alcohol sobriety pilots. He saw up close how current drug laws and prohibition impacts society and undermines the justice and healthcare systems. In 2018, he co-founded the UK’s new Centre for Medicinal Cannabis (CMC). He serves as their policy lead, helping more stakeholders navigate the policy and regulations of the new medicinal regime. He also advises companies in the legal cannabis sectors in Canada, the Channel Islands, Australia and the UK. Blair is currently on the steering committee for a 5-year Stanford University project translating neuroscience research on addiction to policy-makers, and is the co-author of a forthcoming CMC report into the UK’s CBD market.